2 blue chip ASX 200 shares rated as buys

Ramsay Health Care Limited (ASX:RHC) and this blue chip ASX 200 share could be in the buy zone. Here’s why they are highly rated…
The post 2 blue chip ASX 200 shares rated as buys appeared first on The Motley Fool Australia. –

Are you wanting to boost your portfolio with some blue chip ASX 200 shares in May?

Then you might want to take a look at the blue chips listed below. Here’s what you need to know about them:

Goodman Group (ASX: GMG)

The first blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a growing portfolio of warehouses, large scale logistics facilities, and business and office parks. 

Goodman Group has been growing at a consistently solid rate over the last few years. This has been driven by its successful strategy of investing in and developing high quality industrial properties in strategic locations.

Positively, this strong form has continued in FY 2021. In fact, just this morning the company released its third quarter update and revealed further solid growth.

As a result, management believes it is on course to achieve its FY 2021 guidance for operating profit of $1.2 billion and earnings per share growth of 12%.

One broker that is positive on the company is Citi. It currently has a buy rating and $21.00 price target on its shares.

Ramsay Health Care Limited (ASX: RHC)

Another ASX 200 blue chip share to look at is Ramsay Health Care. It is a leading private healthcare company with operations across the world.

Ramsay has been battling tough trading conditions over the last 12 months due to the pandemic. And while things are still not entirely back to normal, it has returned to growth in the ANZ market.

Looking ahead, the company looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

In addition to this, the company has a strong balance sheet and the option of accelerating its growth through expansions and acquisitions.

Earlier this week Goldman Sachs retained its conviction buy rating and $75.00 price target on the company’s shares. Its analysts are positive on its outlook and continue to expect Ramsay to outperform the market’s expectations in FY 2021 and FY 2022.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 blue chip ASX 200 shares rated as buys appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!